Cited 0 times in
Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강영애 | - |
dc.contributor.author | 이혜존 | - |
dc.contributor.author | 조상래 | - |
dc.date.accessioned | 2023-07-12T02:45:47Z | - |
dc.date.available | 2023-07-12T02:45:47Z | - |
dc.date.issued | 2023-06 | - |
dc.identifier.issn | 2193-8229 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/195391 | - |
dc.description.abstract | Introduction: This randomized, double-blind, placebo-controlled, phase 2a trial was conducted to evaluate the safety and immunogenicity of the ID93 + glucopyranosyl lipid adjuvant (GLA)-stable emulsion (SE) vaccine in human immunodeficiency virus (HIV)-negative, previously Bacillus Calmette-Guérin (BCG)-vaccinated, and QuantiFERON-TB-negative healthy adults in South Korea. Methods: Adults (n = 107) with no signs or symptoms of tuberculosis were randomly assigned to receive three intramuscular injections of 2 μg ID93 + 5 μg GLA-SE, 10 μg ID93 + 5 μg GLA-SE, or 0.9% normal saline placebo on days 0, 28, and 56. For safety assessment, data on solicited adverse events (AEs), unsolicited AEs, serious AEs (SAEs), and special interest AEs were collected. Antigen-specific antibody responses were measured using serum enzyme-linked immunosorbent assay. T-cell immune responses were measured using enzyme-linked immunospot and intracellular cytokine staining. Results: No SAEs, deaths, or AEs leading to treatment discontinuation were found. The solicited local and systemic AEs observed were consistent with those previously reported. Compared with adults administered with the placebo, those administered with three intramuscular vaccine injections exhibited significantly higher antigen-specific antibody levels and Type 1 T-helper cellular immune responses. Conclusion: The ID93 + GLA-SE vaccine induced antigen-specific cellular and humoral immune responses, with an acceptable safety profile in previously healthy, BCG-vaccinated, Mycobacterium tuberculosis-uninfected adult healthcare workers. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.language | English | - |
dc.publisher | Adis | - |
dc.relation.isPartOf | INFECTIOUS DISEASES AND THERAPY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Yu Hwa Choi | - |
dc.contributor.googleauthor | Young Ae Kang | - |
dc.contributor.googleauthor | Kwang Joo Park | - |
dc.contributor.googleauthor | Jae Chol Choi | - |
dc.contributor.googleauthor | Kwan Goo Cho | - |
dc.contributor.googleauthor | Da Yeon Ko | - |
dc.contributor.googleauthor | Jun Ho Ahn | - |
dc.contributor.googleauthor | Boram Lee | - |
dc.contributor.googleauthor | Eunsol Ahn | - |
dc.contributor.googleauthor | Yun Ju Woo | - |
dc.contributor.googleauthor | Kwangsoo Jung | - |
dc.contributor.googleauthor | Nan Yul Kim | - |
dc.contributor.googleauthor | Valerie A Reese | - |
dc.contributor.googleauthor | Sasha E Larsen | - |
dc.contributor.googleauthor | Susan L Baldwin | - |
dc.contributor.googleauthor | Steven G Reed | - |
dc.contributor.googleauthor | Rhea N Coler | - |
dc.contributor.googleauthor | Hyejon Lee | - |
dc.contributor.googleauthor | Sang-Nae Cho | - |
dc.identifier.doi | 10.1007/s40121-023-00806-0 | - |
dc.contributor.localId | A00057 | - |
dc.contributor.localId | A04865 | - |
dc.relation.journalcode | J04212 | - |
dc.identifier.eissn | 2193-6382 | - |
dc.identifier.pmid | 37166567 | - |
dc.subject.keyword | GLA-SE | - |
dc.subject.keyword | Immunogenicity | - |
dc.subject.keyword | Safety | - |
dc.subject.keyword | Subunit vaccine | - |
dc.subject.keyword | Tuberculosis | - |
dc.contributor.alternativeName | Kang, Young Ae | - |
dc.contributor.affiliatedAuthor | 강영애 | - |
dc.contributor.affiliatedAuthor | 이혜존 | - |
dc.citation.volume | 12 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1605 | - |
dc.citation.endPage | 1624 | - |
dc.identifier.bibliographicCitation | INFECTIOUS DISEASES AND THERAPY, Vol.12(6) : 1605-1624, 2023-06 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.